
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $6.3B | -- | -- | $3.57 | -- |
07/22/2025 | Q2 | $6.3B | -- | -- | $3.81 | -- |
04/29/2025 | Q1 | $5.4B | $5.3B | $2.00 | $2.16 | -$0.16 |
01/30/2025 | Q4 | $5.3B | $5.3B | $1.90 | $2.06 | -$0.16 |
10/22/2024 | Q3 | $6.2B | $6.2B | $3.18 | $3.54 | -$0.36 |
07/23/2024 | Q2 | $6.3B | $6.3B | $3.50 | $3.49 | $0.01 |
04/23/2024 | Q1 | $5.5B | $5.4B | $1.97 | $2.22 | -$0.25 |
01/25/2024 | Q4 | $5.2B | $5.3B | $1.39 | $1.80 | -$0.41 |
10/24/2023 | Q3 | $6B | $6.1B | $2.95 | $2.78 | $0.17 |
07/25/2023 | Q2 | $6B | $6.2B | $3.07 | $2.69 | $0.38 |
04/25/2023 | Q1 | -- | $5.4B | $1.84 | -- | -- |
01/26/2023 | Q4 | -- | $5.2B | $1.48 | -- | -- |
10/25/2022 | Q3 | -- | $6B | $2.62 | -- | -- |
07/27/2022 | Q2 | -- | $5.9B | $2.21 | -- | -- |
04/26/2022 | Q1 | -- | $5B | $1.41 | -- | -- |
01/27/2022 | Q4 | -- | $4.8B | $1.15 | -- | -- |
10/26/2021 | Q3 | -- | $5.1B | $1.88 | -- | -- |
07/27/2021 | Q2 | -- | $5.4B | $2.42 | -- | -- |
04/27/2021 | Q1 | -- | $4.7B | $1.51 | -- | -- |
01/28/2021 | Q4 | -- | $4.5B | $1.49 | -- | -- |
10/27/2020 | Q3 | -- | $5.1B | $2.55 | -- | -- |
07/28/2020 | Q2 | -- | $4.6B | $2.16 | -- | -- |
04/29/2020 | Q1 | -- | $4.1B | $1.15 | -- | -- |
01/30/2020 | Q4 | -- | $4.1B | $0.89 | -- | -- |
10/22/2019 | Q3 | -- | $4.9B | $2.05 | -- | -- |
07/23/2019 | Q2 | -- | $4.9B | $1.68 | -- | -- |
04/23/2019 | Q1 | -- | $4B | $0.87 | -- | -- |
01/31/2019 | Q4 | -- | $4.1B | $0.36 | -- | -- |
10/25/2018 | Q3 | -- | $4.7B | $1.24 | -- | -- |
07/24/2018 | Q2 | -- | $4.8B | $1.42 | -- | -- |
04/24/2018 | Q1 | -- | $4B | $0.87 | -- | -- |
01/25/2018 | Q4 | -- | $4B | $3.13 | -- | -- |
10/24/2017 | Q3 | -- | $4.5B | $1.11 | -- | -- |
07/20/2017 | Q2 | -- | $3.7B | $1.12 | -- | -- |
04/20/2017 | Q1 | -- | $2.8B | $0.84 | -- | -- |
01/26/2017 | Q4 | -- | $2.8B | $0.72 | -- | -- |
10/25/2016 | Q3 | -- | $3.3B | $1.36 | -- | -- |
07/21/2016 | Q2 | -- | $3.2B | $1.33 | -- | -- |
04/21/2016 | Q1 | -- | $2.6B | $0.58 | -- | -- |
01/28/2016 | Q4 | -- | $2.6B | $0.71 | -- | -- |
10/29/2015 | Q3 | -- | $3.2B | $1.32 | -- | -- |
Sherwin-Williams reported $5.3B worth of top line sales in its most recent quarter.
Sherwin-Williams announced earnings per share of $2.00 which represents a miss of analyst forecast a $2.16 per share.
Sherwin-Williams reported $2.6B that represents $10.14 per share over the last quarter.
Sherwin-Williams's earnings are forecast to grow from $10.55 per share to $11.29 per share next year representing an increase of 12.7%.
Sherwin-Williams's next earnings date is July 22, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.